Aliver

The ALIVER project, funded by the European Union's Horizon 2020 research and innovation programme, focuses on developing the Dialive™ device. This device aims to treat liver failure by reversing the accumulation of protein-bound toxins and reducing susceptibility to infections, providing an alternative to liver transplantation. The primary beneficiaries of this project are patients suffering from liver failure who require innovative treatment options beyond traditional transplantation.